Diabetes has an annual growth rate of 8% and neuropathy is among the most virulent complications of that chronic disease. Its main effect is a loss of sensitivity in the feet, which can lead to ulcers and ultimately to amputations.
This disease leads to 600,000 diabetics requiring amputations every year across the world, 100,000 in the US only. The OECD has estimated it to cost €38 billion per year across the world.
A comprehensive foot-care strategy combining education, prevention, multidisciplinary therapeutic management and close monitoring could reduce the amputation rate by up to 85%.
We want to disrupt the restraints in diabetic patients’ life with state-of-the-art technology that can monitor plantar pressure in real time.
Our insoles are intended for daily use, as they are comfortable and ergonomic shoe insoles, and the patient will be warned instantly if a change in the plantar pressure is detected.
The insoles will also help the doctor to know where within and when to examine the feet.
With over a hundred pressure sensors, FeetMe insoles enable to visualize a detailed pressure map of the feet. Without this precision it would be impossible to prevent a wound early enough.
Thanks to an ergonomic and intuitive software, patients can react early enough and easily deal with potential danger. Without being intrusive, FeetMe insoles help building a better comprehension of the issue.
FeetMe insoles are designed for a convenient daily use as they perfectly fit in the shoes. The electronic device is entirely incorporated and fully autonomous with its long life battery.
FeetMe understands that all disease-related data should be kept personal and is committed to guarantee the privacy of each patient.